These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19399852)

  • 1. Specific labeling with potent radiolabels alters the uptake of cell-penetrating peptides.
    Walther C; Ott I; Gust R; Neundorf I
    Biopolymers; 2009; 92(5):445-51. PubMed ID: 19399852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of carrier peptides for the delivery of nucleic acid drugs in primary cells.
    Rennert R; Neundorf I; Jahnke HG; Suchowerskyj P; Dournaud P; Robitzki A; Beck-Sickinger AG
    ChemMedChem; 2008 Feb; 3(2):241-53. PubMed ID: 18205166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoding the entry of two novel cell-penetrating peptides in HeLa cells: lipid raft-mediated endocytosis and endosomal escape.
    Foerg C; Ziegler U; Fernandez-Carneado J; Giralt E; Rennert R; Beck-Sickinger AG; Merkle HP
    Biochemistry; 2005 Jan; 44(1):72-81. PubMed ID: 15628847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonin-derived peptide carriers: mechanisms and application.
    Rennert R; Neundorf I; Beck-Sickinger AG
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):485-98. PubMed ID: 18160173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantum dot-carrier peptide conjugates suitable for imaging and delivery applications.
    Walther C; Meyer K; Rennert R; Neundorf I
    Bioconjug Chem; 2008 Dec; 19(12):2346-56. PubMed ID: 18991369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct uptake routes of cell-penetrating peptide conjugates.
    Lundin P; Johansson H; Guterstam P; Holm T; Hansen M; Langel U; EL Andaloussi S
    Bioconjug Chem; 2008 Dec; 19(12):2535-42. PubMed ID: 19012426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of uptake of cell penetrating peptides and their cargoes in permeabilized wheat immature embryos.
    Chugh A; Eudes F
    FEBS J; 2008 May; 275(10):2403-14. PubMed ID: 18397318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery.
    Massodi I; Bidwell GL; Raucher D
    J Control Release; 2005 Nov; 108(2-3):396-408. PubMed ID: 16157413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced cellular uptake and cytotoxicity studies of organometallic bioconjugates of the NLS peptide in Hep G2 cells.
    Noor F; Kinscherf R; Bonaterra GA; Walczak S; Wölfl S; Metzler-Nolte N
    Chembiochem; 2009 Feb; 10(3):493-502. PubMed ID: 19115329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein delivery by the cell-penetrating peptide YTA2.
    Myrberg H; Lindgren M; Langel U
    Bioconjug Chem; 2007; 18(1):170-4. PubMed ID: 17226970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed analysis concerning the biodistribution and metabolism of human calcitonin-derived cell-penetrating peptides.
    Neundorf I; Rennert R; Franke J; Közle I; Bergmann R
    Bioconjug Chem; 2008 Aug; 19(8):1596-603. PubMed ID: 18651757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acyl moieties: improving Pro-rich peptide uptake inside HeLa cells.
    Fernández-Carneado J; Kogan MJ; Van Mau N; Pujals S; López-Iglesias C; Heitz F; Giralt E
    J Pept Res; 2005 Jun; 65(6):580-90. PubMed ID: 15885117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-SAP: a new, noncytotoxic, and fully protease resistant cell-penetrating peptide.
    Pujals S; Fernández-Carneado J; Ludevid MD; Giralt E
    ChemMedChem; 2008 Feb; 3(2):296-301. PubMed ID: 18058782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cellular uptake using 22 CPPs in 4 different cell lines.
    Mueller J; Kretzschmar I; Volkmer R; Boisguerin P
    Bioconjug Chem; 2008 Dec; 19(12):2363-74. PubMed ID: 19053306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and application of peptides as drug carriers.
    Rennert R; Neundorf I; Beck-Sickinger AG
    Methods Mol Biol; 2009; 535():389-403. PubMed ID: 19377983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting cell-penetrating peptides.
    Hansen M; Kilk K; Langel U
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):572-9. PubMed ID: 18045726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing novel hCT derived cell-penetrating peptides with improved metabolic stability.
    Rennert R; Wespe C; Beck-Sickinger AG; Neundorf I
    Biochim Biophys Acta; 2006 Mar; 1758(3):347-54. PubMed ID: 16380074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel cell-penetrating calpain substrate.
    Bánóczi Z; Alexa A; Farkas A; Friedrich P; Hudecz F
    Bioconjug Chem; 2008 Jul; 19(7):1375-81. PubMed ID: 18529021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD.
    Watkins CL; Brennan P; Fegan C; Takayama K; Nakase I; Futaki S; Jones AT
    J Control Release; 2009 Dec; 140(3):237-44. PubMed ID: 19409429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new rapid cell-penetrating peptide based strategy to produce bacterial ghosts for plasmid delivery.
    Palm-Apergi C; Hällbrink M
    J Control Release; 2008 Nov; 132(1):49-54. PubMed ID: 18786580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.